This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ nalidixic acid sodium salt (antibiotic)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Urinary Tract Infections (UTIs): Nalidixic acid is most commonly used to treat uncomplicated urinary tract infections caused by susceptible gram-negative bacteria, including Escherichia coli. It works by inhibiting bacterial DNA replication and is concentrated in the urine, making it effective for treating infections in the urinary tract.

  2. Bacterial Prostatitis: Nalidixic acid may also be used to treat bacterial prostatitis, which is an inflammation of the prostate gland caused by a bacterial infection. It is particularly effective against gram-negative bacteria commonly associated with prostatitis.

  3. Dosage and Administration: Nalidixic acid is usually administered orally in the form of tablets or capsules. The dosage and duration of treatment depend on the severity of the infection, the type of bacteria involved, and the patient's age and kidney function. It is important to take the medication exactly as prescribed by a healthcare provider and to complete the full course of treatment.

  4. Adverse Effects: Common side effects of nalidixic acid may include:

    • Gastrointestinal disturbances: Such as nausea, vomiting, diarrhea, and abdominal pain.
    • Central nervous system effects: Including headache, dizziness, and lightheadedness.
    • Hypersensitivity reactions: Such as rash, itching, and allergic dermatitis. Serious allergic reactions are rare but can occur.
  5. Drug Interactions: Nalidixic acid may interact with other medications, including antacids containing magnesium or aluminum, which can reduce its absorption when taken together. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting nalidixic acid therapy.

  6. Monitoring: During treatment with nalidixic acid, patients may require monitoring for signs of adverse effects, including gastrointestinal disturbances and allergic reactions. It is essential to report any new or worsening symptoms to your healthcare provider.

  7. Resistance and Sensitivity Testing: Due to the emergence of antibiotic resistance, it is essential to perform culture and sensitivity testing before initiating nalidixic acid therapy to ensure its effectiveness against the specific bacterial strain causing the infection.

  8. Duration of Treatment: The duration of nalidixic acid treatment varies depending on the type and severity of the infection. It is important to complete the full course of treatment as prescribed by your healthcare provider, even if symptoms improve before the medication is finished.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of nalidixic acid sodium salt (antibiotic) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Increases
species Akkermansia muciniphila Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium animalis Increases
species Bifidobacterium bifidum Increases
species Bifidobacterium breve Increases
species Bifidobacterium catenulatum Increases
species Bifidobacterium longum Reduces
species Bifidobacterium pseudocatenulatum Increases
species Bifidobacterium pseudolongum Increases
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by nalidixic acid sodium salt (antibiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Akkermansiaceae family Decreases 👪 Source Study
Bifidobacteriaceae family Increases 📓 Source Study
Escherichia genus Decreases 👪 Source Study
Clostridium genus Decreases 👪 Source Study Pathogen
Clostridioides genus Decreases 👪 Source Study
Blautia genus Decreases 👪 Source Study
Veillonella genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Bifidobacterium genus Decreases 👪 Source Study
Eggerthella genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Collinsella genus Decreases 👪 Source Study proinflammatory
Odoribacter genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Akkermansia genus Decreases 📓 Source Study
Lachnospira genus Decreases 👪 Source Study
Lacrimispora genus Decreases 👪 Source Study
Lacticaseibacillus genus Decreases 👪 Source Study
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
Dorea genus Decreases 👪 Source Study
Ruminococcus genus Decreases 👪 Source Study
Thomasclavelia genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Enterocloster genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
Aeriscardovia genus Increases 👶 Source Study
Alloscardovia genus Increases 👶 Source Study
Bombiscardovia genus Increases 👶 Source Study
Galliscardovia genus Increases 👶 Source Study
Gardnerella genus Increases 👶 Source Study
Neoscardovia genus Increases 👶 Source Study
Parascardovia genus Increases 👶 Source Study
Pseudoscardovia genus Increases 👶 Source Study
Scardovia genus Increases 👶 Source Study
Bifidobacterium genus Increases 📓 Source Study
Escherichia coli O1:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O139:H1 no rank Decreases 👶 Source Study
Escherichia coli O141:H4 no rank Decreases 👶 Source Study
Escherichia coli O145:H34 no rank Decreases 👶 Source Study
Escherichia coli O15:H12 no rank Decreases 👶 Source Study
Escherichia coli O155:H21 no rank Decreases 👶 Source Study
Escherichia coli O158:H23 no rank Decreases 👶 Source Study
Escherichia coli O16:H48 no rank Decreases 👶 Source Study
Escherichia coli O170:H18 no rank Decreases 👶 Source Study
Escherichia coli O18ac:H14 no rank Decreases 👶 Source Study
Escherichia coli O19:H7 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H4 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H5 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O20:H12 no rank Decreases 👶 Source Study
Escherichia coli O25:H16 no rank Decreases 👶 Source Study
Escherichia coli O55:H7 no rank Decreases 👶 Source Study
Escherichia coli O68:H12 no rank Decreases 👶 Source Study
Escherichia coli O7:H15 no rank Decreases 👶 Source Study
Escherichia coli O78:H51 no rank Decreases 👶 Source Study
Escherichia coli O80:H26 no rank Decreases 👶 Source Study
Escherichia coli O84:H7 no rank Decreases 👶 Source Study
Escherichia coli O85:H1 no rank Decreases 👶 Source Study
Clostridium perfringens A no rank Decreases 👶 Source Study
Clostridium perfringens B no rank Decreases 👶 Source Study
Clostridium perfringens D no rank Decreases 👶 Source Study
Clostridium perfringens E no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
unclassified Akkermansia no rank Decreases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Bifidobacterium no rank Increases 👶 Source Study
Bifidobacteriales order Increases 👪 Source Study
Escherichia coli O121 serogroup Decreases 👶 Source Study
Escherichia coli O145 serogroup Decreases 👶 Source Study
Escherichia coli O155 serogroup Decreases 👶 Source Study
Escherichia coli O157 serogroup Decreases 👶 Source Study
Escherichia coli O177 serogroup Decreases 👶 Source Study
Escherichia coli O26 serogroup Decreases 👶 Source Study
Escherichia coli O3 serogroup Decreases 👶 Source Study
Escherichia coli O43 serogroup Decreases 👶 Source Study
Escherichia coli O78 serogroup Decreases 👶 Source Study
Escherichia coli O86 serogroup Decreases 👶 Source Study
Escherichia coli O91 serogroup Decreases 👶 Source Study
Escherichia coli H20 serotype Decreases 👶 Source Study
Escherichia coli O1:H42 serotype Decreases 👶 Source Study
Escherichia coli O1:HNT serotype Decreases 👶 Source Study
Escherichia coli O10:H32 serotype Decreases 👶 Source Study
Escherichia coli O100:H21 serotype Decreases 👶 Source Study
Escherichia coli O103:H2 serotype Decreases 👶 Source Study
Escherichia coli O104:H4 serotype Decreases 👶 Source Study
Escherichia coli O111:H- serotype Decreases 👶 Source Study
Escherichia coli O111:H8 serotype Decreases 👶 Source Study
Escherichia coli O111:NM serotype Decreases 👶 Source Study
Escherichia coli O112ab:H8 serotype Decreases 👶 Source Study
Escherichia coli O112ac:H19 serotype Decreases 👶 Source Study
Escherichia coli O113:H21 serotype Decreases 👶 Source Study
Escherichia coli O114:H49 serotype Decreases 👶 Source Study
Escherichia coli O121:H19 serotype Decreases 👶 Source Study
Escherichia coli O125ac:K+:H10 serotype Decreases 👶 Source Study
Escherichia coli O126:H45 serotype Decreases 👶 Source Study
Escherichia coli O127:H6 serotype Decreases 👶 Source Study
Escherichia coli O128ac:H12 serotype Decreases 👶 Source Study
Escherichia coli O139:H28 serotype Decreases 👶 Source Study
Escherichia coli O145:H25 serotype Decreases 👶 Source Study
Escherichia coli O145:H28 serotype Decreases 👶 Source Study
Escherichia coli O145:NM serotype Decreases 👶 Source Study
Escherichia coli O15:H18 serotype Decreases 👶 Source Study
Escherichia coli O150:H6 serotype Decreases 👶 Source Study
Escherichia coli O152:H23 serotype Decreases 👶 Source Study
Escherichia coli O157:H- serotype Decreases 👶 Source Study
Escherichia coli O157:H43 serotype Decreases 👶 Source Study
Escherichia coli O157:H7 serotype Decreases 👶 Source Study bloody diarrhea
Escherichia coli O16:H6 serotype Decreases 👶 Source Study
Escherichia coli O167:H26 serotype Decreases 👶 Source Study
Escherichia coli O174:H21 serotype Decreases 👶 Source Study
Escherichia coli O176:H45 serotype Decreases 👶 Source Study
Escherichia coli O2:H6 serotype Decreases 👶 Source Study
Escherichia coli O2:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O25:H1 serotype Decreases 👶 Source Study
Escherichia coli O25:NM serotype Decreases 👶 Source Study
Escherichia coli O26:H11 serotype Decreases 👶 Source Study
Escherichia coli O44:H18 serotype Decreases 👶 Source Study
Escherichia coli O45:H2 serotype Decreases 👶 Source Study
Escherichia coli O6:H16 serotype Decreases 👶 Source Study
Escherichia coli O6:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O7:H4 serotype Decreases 👶 Source Study
Escherichia coli O7:K1 serotype Decreases 👶 Source Study
Escherichia coli O78:H4 serotype Decreases 👶 Source Study
Escherichia coli O8:H8 serotype Decreases 👶 Source Study
Escherichia coli O89m:H10 serotype Decreases 👶 Source Study
Escherichia coli O89m:H9 serotype Decreases 👶 Source Study
Escherichia coli O9:H10 serotype Decreases 👶 Source Study
Escherichia coli O99:H6 serotype Decreases 👶 Source Study
Escherichia coli species Decreases 📓 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Bacteroides xylanisolvens species Decreases 📓 Source Study
Clostridium perfringens species Decreases 📓 Source Study Food poisoning, gas gangrene
Bacteroides ovatus species Decreases 📓 Source Study
Clostridioides difficile species Decreases 📓 Source Study Colitis
Bacteroides caccae species Decreases 📓 Source Study
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Blautia obeum species Decreases 📓 Source Study
Bifidobacterium longum species Decreases 📓 Source Study
Veillonella parvula species Decreases 📓 Source Study
Eggerthella lenta species Decreases 📓 Source Study
Roseburia hominis species Decreases 📓 Source Study
Bifidobacterium adolescentis species Decreases 📓 Source Study
Collinsella aerofaciens species Decreases 📓 Source Study
Odoribacter splanchnicus species Decreases 📓 Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Akkermansia muciniphila species Decreases 📓 Source Study High Levels linked to long-lived individuals
Streptococcus parasanguinis species Decreases 📓 Source Study
Lachnospira eligens species Decreases 📓 Source Study
Lacrimispora saccharolytica species Decreases 📓 Source Study
Lacticaseibacillus paracasei species Decreases 📓 Source Study
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Dorea formicigenerans species Decreases 📓 Source Study
Ruminococcus bromii species Decreases 📓 Source Study
Thomasclavelia ramosa species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Bacteroides thetaiotaomicron species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Akkermansia glycaniphila species Decreases 👶 Source Study
Candidatus Akkermansia intestinavium species Decreases 👶 Source Study
Enterocloster bolteae species Decreases 📓 Source Study
Bilophila wadsworthia species Decreases 📓 Source Study
Bifidobacterium actinocoloniiforme species Increases 👶 Source Study
Bifidobacterium adolescentis species Increases 👶 Source Study
Bifidobacterium aesculapii species Increases 👶 Source Study
Bifidobacterium angulatum species Increases 👶 Source Study
Bifidobacterium animalis species Increases 👶 Source Study
Bifidobacterium asteroides species Increases 👶 Source Study
Bifidobacterium avesanii species Increases 👶 Source Study
Bifidobacterium biavatii species Increases 👶 Source Study
Bifidobacterium bohemicum species Increases 👶 Source Study
Bifidobacterium bombi species Increases 👶 Source Study
Bifidobacterium boum species Increases 👶 Source Study
Bifidobacterium callitrichidarum species Increases 👶 Source Study
Bifidobacterium callitrichos species Increases 👶 Source Study
Bifidobacterium catenulatum species Increases 👶 Source Study
Bifidobacterium choerinum species Increases 👶 Source Study
Bifidobacterium commune species Increases 👶 Source Study
Bifidobacterium coryneforme species Increases 👶 Source Study
Bifidobacterium cuniculi species Increases 👶 Source Study
Bifidobacterium dentium species Increases 👶 Source Study
Bifidobacterium eulemuris species Increases 👶 Source Study
Bifidobacterium faecale species Increases 👶 Source Study
Bifidobacterium gallicum species Increases 👶 Source Study
Bifidobacterium imperatoris species Increases 👶 Source Study
Bifidobacterium indicum species Increases 👶 Source Study
Bifidobacterium lemurum species Increases 👶 Source Study
Bifidobacterium longum species Increases 👶 Source Study
Bifidobacterium magnum species Increases 👶 Source Study
Bifidobacterium merycicum species Increases 👶 Source Study
Bifidobacterium minimum species Increases 👶 Source Study
Bifidobacterium mongoliense species Increases 👶 Source Study
Bifidobacterium moukalabense species Increases 👶 Source Study
Bifidobacterium myosotis species Increases 👶 Source Study
Bifidobacterium porcinum species Increases 👶 Source Study
Bifidobacterium pseudocatenulatum species Increases 👶 Source Study
Bifidobacterium pseudolongum species Increases 👶 Source Study
Bifidobacterium psychraerophilum species Increases 👶 Source Study
Bifidobacterium pullorum species Increases 👶 Source Study
Bifidobacterium reuteri species Increases 👶 Source Study
Bifidobacterium ruminantium species Increases 👶 Source Study
Bifidobacterium saguini species Increases 👶 Source Study
Bifidobacterium scardovii species Increases 👶 Source Study
Bifidobacterium simiae species Increases 👶 Source Study
Bifidobacterium sp. group II-3 species Increases 👶 Source Study
Bifidobacterium sp. N5G01 species Increases 👶 Source Study
Bifidobacterium stellenboschense species Increases 👶 Source Study
Bifidobacterium stercoris species Increases 👶 Source Study
Bifidobacterium subtile species Increases 👶 Source Study
Bifidobacterium thermacidophilum species Increases 👶 Source Study
Bifidobacterium thermophilum species Increases 👶 Source Study
Bifidobacterium tissieri species Increases 👶 Source Study
Bifidobacterium tsurumiense species Increases 👶 Source Study
Bifidobacterium sp. species Increases 👶 Source Study
Bifidobacterium sp. 113 species Increases 👶 Source Study
Bifidobacterium sp. 120 species Increases 👶 Source Study
Bifidobacterium sp. 138 species Increases 👶 Source Study
Bifidobacterium sp. 65947 species Increases 👶 Source Study
Bifidobacterium sp. h12 species Increases 👶 Source Study
Bifidobacterium sp. JCM 6439 species Increases 👶 Source Study
Bifidobacterium sp. M45 species Increases 👶 Source Study
Bifidobacterium sp. MC_8 species Increases 👶 Source Study
Bifidobacterium sp. MSTE12 species Increases 👶 Source Study
Bifidobacterium sp. MSX5B species Increases 👶 Source Study
Bifidobacterium sp. PL1 species Increases 👶 Source Study
Bifidobacterium bifidum species Increases 📓 Source Study
Bifidobacterium breve species Increases 📓 Source Study
Bifidobacterium bifidum BGN4 strain Increases 👶 Source Study
Bifidobacterium bifidum LMG 13195 strain Increases 👶 Source Study
Bifidobacterium bifidum PRL2010 strain Increases 👶 Source Study
Bifidobacterium bifidum S17 strain Increases 👶 Source Study
Bifidobacterium breve 12L strain Increases 👶 Source Study
Bifidobacterium breve 31L strain Increases 👶 Source Study
Bifidobacterium breve 689b strain Increases 👶 Source Study
Bifidobacterium breve ACS-071-V-Sch8b strain Increases 👶 Source Study
Bifidobacterium breve DPC 6330 strain Increases 👶 Source Study
Bifidobacterium breve DSM 20213 = JCM 1192 strain Increases 👶 Source Study
Bifidobacterium breve HPH0326 strain Increases 👶 Source Study
Bifidobacterium breve JCM 7017 strain Increases 👶 Source Study
Bifidobacterium breve JCM 7019 strain Increases 👶 Source Study
Bifidobacterium breve JCP7499 strain Increases 👶 Source Study
Bifidobacterium breve S27 strain Increases 👶 Source Study
Bifidobacterium longum subsp. infantis subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. longum subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. suillum subspecies Decreases 👶 Source Study
Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases 👶 Source Study
Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases 👶 Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Bifidobacterium pullorum subsp. gallinarum subspecies Increases 👶 Source Study
Bifidobacterium pullorum subsp. saeculare subspecies Increases 👶 Source Study

Impact of nalidixic acid sodium salt (antibiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0 0
Acne 0.1 0.1
ADHD 2.7 1.4 0.93
Age-Related Macular Degeneration and Glaucoma 0.6 0.1 5
Allergic Rhinitis (Hay Fever) 1.8 0.6 2
Allergies 6.1 2.6 1.35
Allergy to milk products 2.8 0.6 3.67
Alopecia (Hair Loss) 1.1 1.1
Alzheimer's disease 4.5 5 -0.11
Amyotrophic lateral sclerosis (ALS) Motor Neuron 3.4 1.9 0.79
Ankylosing spondylitis 3.3 1.2 1.75
Anorexia Nervosa 0.1 2.1 -20
Antiphospholipid syndrome (APS) 1.4 0 0
Asthma 1.8 1.8 0
Atherosclerosis 0.8 1.9 -1.37
Atrial fibrillation 2.4 1.1 1.18
Autism 8.5 7 0.21
Barrett esophagus cancer 0.6 0.3 1
benign prostatic hyperplasia 0.5 0.5
Biofilm 2 0.6 2.33
Bipolar Disorder 1.2 1.3 -0.08
Brain Trauma 0.3 1.5 -4
Cancer (General) 0.3 3.3 -10
Carcinoma 3.3 2.1 0.57
Celiac Disease 3.2 3.6 -0.13
Cerebral Palsy 1.5 1.5 0
Chronic Fatigue Syndrome 6.4 4.1 0.56
Chronic Kidney Disease 1.3 1.1 0.18
Chronic Lyme 0.8 -0.8
Chronic Obstructive Pulmonary Disease (COPD) 2.2 0.6 2.67
Chronic Urticaria (Hives) 2.7 1.5 0.8
Coagulation / Micro clot triggering bacteria 1.9 1.3 0.46
Colorectal Cancer 5.2 0.4 12
Constipation 1.4 0.8 0.75
Coronary artery disease 0.5 0.9 -0.8
COVID-19 11.1 10 0.11
Crohn's Disease 7.8 4.6 0.7
cystic fibrosis 1.6 0.8 1
deep vein thrombosis 1.5 0.9 0.67
Depression 9.4 7.6 0.24
Dermatomyositis 0.4 0.4
Eczema 1.6 2.3 -0.44
Endometriosis 3.1 1.5 1.07
Eosinophilic Esophagitis 0.2 0.4 -1
Epilepsy 3.5 2.2 0.59
Fibromyalgia 2.2 0.9 1.44
Functional constipation / chronic idiopathic constipation 5.5 3.2 0.72
gallstone disease (gsd) 2.5 0.6 3.17
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.8 1.2 0.5
Generalized anxiety disorder 2.3 1.2 0.92
giant cell arteritis 0.5 -0.5
Glioblastoma 0.3 -0.3
Graves' disease 0.8 1.5 -0.88
Halitosis 1 0.3 2.33
Hashimoto's thyroiditis 1.8 0.5 2.6
Hidradenitis Suppurativa 0.6 0.4 0.5
High Histamine/low DAO 3.6 0.2 17
hypercholesterolemia (High Cholesterol) 0.8 0.6 0.33
hyperglycemia 0.8 1.8 -1.25
Hyperlipidemia (High Blood Fats) 0.6 0.4 0.5
hypersomnia 0.5 -0.5
hypertension (High Blood Pressure 3 4.6 -0.53
Hypothyroidism 0.1 0.8 -7
Hypoxia 0.8 0.8
IgA nephropathy (IgAN) 0.1 2.1 -20
Inflammatory Bowel Disease 4.8 5.6 -0.17
Insomnia 1.1 1 0.1
Intelligence 0.5 0.5
Intracranial aneurysms 1.1 0.3 2.67
Irritable Bowel Syndrome 5.2 3.5 0.49
Liver Cirrhosis 4.4 2.9 0.52
Long COVID 6 7.4 -0.23
Low bone mineral density 0.6 -0.6
Lung Cancer 1.5 1.5 0
Mast Cell Issues / mastitis 0.9 0.2 3.5
ME/CFS with IBS 1 1.7 -0.7
ME/CFS without IBS 2 1.1 0.82
Menopause 1.7 1.7
Metabolic Syndrome 9.4 8.1 0.16
Mood Disorders 13.3 8 0.66
multiple chemical sensitivity [MCS] 1.7 0.4 3.25
Multiple Sclerosis 5.1 4.5 0.13
Multiple system atrophy (MSA) 2.5 0.6 3.17
neuropathic pain 0.3 2 -5.67
Neuropathy (all types) 1.1 0.5 1.2
neuropsychiatric disorders (PANDAS, PANS) 1.3 1.3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3.2 3.7 -0.16
NonCeliac Gluten Sensitivity 1.9 0.5 2.8
Obesity 7.5 4.3 0.74
obsessive-compulsive disorder 7.7 2 2.85
Osteoarthritis 2.2 0.2 10
Osteoporosis 2.4 1.5 0.6
pancreatic cancer 0.6 0.6
Parkinson's Disease 8.4 5.8 0.45
Polycystic ovary syndrome 2.5 1.9 0.32
Postural orthostatic tachycardia syndrome 0.6 0.6
Premenstrual dysphoric disorder 0.8 0.2 3
primary biliary cholangitis 0.2 0.3 -0.5
Psoriasis 5.2 1.7 2.06
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 5 4.4 0.14
Rosacea 0.2 1 -4
Schizophrenia 6.5 1.6 3.06
scoliosis 0.7 -0.7
Sjögren syndrome 3 1.6 0.88
Sleep Apnea 0.9 2.1 -1.33
Slow gastric motility / Gastroparesis 2.1 2.1
Small Intestinal Bacterial Overgrowth (SIBO) 1.5 0.3 4
Stress / posttraumatic stress disorder 3.2 2.5 0.28
Systemic Lupus Erythematosus 4.1 1.6 1.56
Tic Disorder 0.9 0.5 0.8
Tourette syndrome 0.3 0.4 -0.33
Type 1 Diabetes 4.4 1.9 1.32
Type 2 Diabetes 8.4 7.5 0.12
Ulcerative colitis 4.3 4.9 -0.14
Unhealthy Ageing 4.5 1 3.5
Vitiligo 1.8 1 0.8

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2024 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [34.204.176 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [34.204.176 ]